Skip to content
10-Q

Quarterly Report

SANARA MEDTECH INC. SMTI

0001493152-26-022479

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 9.16M sh
Shares Diluted Q1 2026 · Mar 31, 2026 8.99M sh
Shares Diluted Q1 2026 · Mar 31, 2025 8.57M sh
Capex Q1 2026 · Mar 31, 2026 $43.77K
Capex Q1 2026 · Mar 31, 2025 $1.72M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.47M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2M
Long Term Debt Q1 2026 · Mar 31, 2026 $46.23M
Long Term Debt Q1 2026 · Dec 31, 2025 $45.97M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $13.59M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $16.58M
Stockholders Equity Q1 2026 · Mar 31, 2026 $7.03M
Stockholders Equity Q1 2026 · Dec 31, 2025 $5.94M
Current Liabilities Q1 2026 · Mar 31, 2026 $13.7M
Current Liabilities Q1 2026 · Dec 31, 2025 $18.63M
Total Liabilities Q1 2026 · Mar 31, 2026 $62.26M
Total Liabilities Q1 2026 · Dec 31, 2025 $67.01M
Current Assets Q1 2026 · Mar 31, 2026 $31.2M
Current Assets Q1 2026 · Dec 31, 2025 $33.54M
Total Assets Q1 2026 · Mar 31, 2026 $69.28M
Total Assets Q1 2026 · Dec 31, 2025 $72.94M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.05
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.41
Eps Basic Q1 2026 · Mar 31, 2026 $0.05
Eps Basic Q1 2026 · Mar 31, 2025 −$0.41
Sga Expense Q1 2026 · Mar 31, 2026 $21.88M
Sga Expense restated Q1 2026 · Mar 31, 2025 $19.13M
Rd Expense Q1 2026 · Mar 31, 2026 $759.59K
Rd Expense restated Q1 2026 · Mar 31, 2025 $950.36K
Net Income Q1 2026 · Mar 31, 2026 $458.96K
Net Income Q1 2026 · Mar 31, 2025 −$3.53M
Operating Income Q1 2026 · Mar 31, 2026 $2.65M
Operating Income restated Q1 2026 · Mar 31, 2025 $825.53K
Gross Profit Q1 2026 · Mar 31, 2026 $25.87M
Gross Profit Q1 2026 · Mar 31, 2025 $21.6M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.92M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.83M
Revenue Q1 2026 · Mar 31, 2026 $27.8M
Revenue Q1 2026 · Mar 31, 2025 $23.43M